A novel antibiotic tautomycin induced manyblebs on the surface of K562humanchronic myeloid leukemia cells, similar to the morphological change induced by phorbol esters. However, tautomycin did not induce nitroblue tetrazolium reducing activity, when HL60human promyelocytic leukemia cells were caused to differentiate by quinomycin into mature granulocytes. It did not induce spread of HL60cells, one of the phenotypes of mature macrophages. In addition, it did not compete with phorbol dibutyrate to bind to the cell surface of K562 cells. However, tautomycin significantly activated protein kinase C (PKC) extracted from K562 cells. These results indicate that tautomycin is a new activator of PKC, distinct from phorbol esters.
A novel antibiotic tautomycin induced manyblebs on the surface of K562humanchronic myeloid leukemia cells, similar to the morphological change induced by phorbol esters. However, tautomycin did not induce nitroblue tetrazolium reducing activity, when HL60human promyelocytic leukemia cells were caused to differentiate by quinomycin into mature granulocytes. It did not induce spread of HL60cells, one of the phenotypes of mature macrophages. In addition, it did not compete with phorbol dibutyrate to bind to the cell surface of K562 cells. However, tautomycin significantly activated protein kinase C (PKC) extracted from K562 cells. These results indicate that tautomycin is a new activator of PKC, distinct from phorbol esters.
Phorbol esters are tumor promoters and have various biological activities which are attributed to the activation of protein kinase C (PKC), a high affinity receptor for these compounds1-^. Thus, PKCis assumed to play an important role in various biological reactions in eukaryotic cells. We recently found that phorbol esters induced many blebs on the cell surface of K562 human chronic myeloid leukemia cells50. Bleb formation seemed to be associated with the activation of PKCbecause the inducing activity of phorbol esters was correlated with their tumor promoting activity and because it was prevented by specific inhibitors of PKC. Screening of many kinds of biologically active substances for inducing bleb formation, revealed that the cytochalasins but not colchicine induced a similar morphological change, indicating that the micro filament system maybe involved. Since it is a rapid effect and easily observable microscopically, it is suitable for screening of modulators of PKC.
Here, we describe the induction of bleb formation by a novel antibiotic tautomycin, using the above screening system. Tautomycin is an antibiotic found in our laboratory4). It had strong toxicity against a variety of eukaryotic cells including fungi, yeasts and animal cells. It showed an excellent protective effect against cucumber gray mold in the pot test at the dose of 6 ppm. The structure is under investigation.
Materials and Methods Cell Culture
The human leukemic cell lines, HL60 and K562, were cultured using RPMI1640 medium supplemented with antibiotics and 10 %fetal bovine serum. Nitroblue Tetrazolium (NBT) Reducing Activity 933 HL60 cells were differentiated into mature granulocytes by culturing for 3 days at 37°C in the presence of 1 ng/ml quinomycin. Cells were washed three times to remove quinomycin and cultured with appropriate agents in the presence of 1 mg/ml NBTfor 1 hour at 37°C. Cells with blue-black deposits of formazanwere counted microscopically.
Binding Assay of [3H]Phorbol Dibutyrate Experiments were carried out according to the method described by Solanki et #/.5). Each tube contained K562 cells (2 x lO6 cells) and 10 ng/ml [3H]phorbol dibutyrate (PDBu) and appropriate agents in 0.25 ml of RPMI1640medium (without fetal bovine serum). The incubation was carried out for 45 minutes at 4°C and the reaction was terminated by adding 0.5 ml of cold phosphate-buffered saline (PBS, 0.8% NaCl, pH 7.4). The tubes were immediately centrifuged at 1,500xg for 5 minutes at 25°C. The supernatant was carefully removed by aspiration and pelleted cells were further washed three times with 0.5 ml of ice-cold PBS. Finally cells were filtered on a glass filter. Radioactivity on filters was counted by liquid scintillation system.
Partial Purification of PKC PKC was partially purified as described by Forsbeck et alfi. K562 cells (1~3 x lO8 cells) were harvested from late log cultures. They were then washed twice with PBS and centrifuged at 1,000 xg for 5 minutes. The washed cell pellet was suspended in 3 ml ice-cold 4 him EDTA, 1 mMethylene glycol bis(2-aminoethylether) tetraacetic acid (EGTA), 40 mMTris-HCl (pH 7.5), homogenized with ten strokes in a Teflon-glass homogenizer, and treated for 20 seconds in a sonicator water bath. The lysed cell suspension was then mixed with an equal volume of 40 mMTris-HCl (pH 7.5), 0.66 m sucrose, 0.1 m mercaptoethanol, 1 % Triton X-100 and centrifuged at 100,000 xg for 60 minutes at 4°C. The resultant high speed supernatant was applied to a 2-ml bed volume BEAE-Sephacel column equilibrated in 20mMTris-HCl (pH 7.5) -2mMEDTA-0.5 mMEGTA. The column was washed with 4 ml equilibrating buffer, then 4 ml equilibrating buffer containing 50 mMNaCl. PKC was eluted with 4 ml equilibrating buffer containing 150 mMNaCl. The elute was suspended in equal volume of glycerol and stored at -20°C until used.
PKC Assay PKCactivity was determined by measuring the Ca2+ and phospholipid-dependent phosphotransferase reaction between [j-32P]ATP and histone III-S in the presence of PKC7). Each tube contained 20mMTris-HCl (pH 7.5), 5 rm 2-mercaptoethanol, 10mMMgCl2, 1 him CaCl2 (or 1 mMEGTA), phosphatidylinositol (20 //g/ml) (or no phospholipid), 70^m [>-32P]ATP, histone III-S (0.67 mg/ml), 15 /ug partially purified PKCand where indicated, various agents, in 200 p\. Reaction was initiated by the addition of enzyme and incubated at 30°C for 5 minutes. Reaction was terminated by the 1 ml 10% TCA.5 jbd bovine serum was added as carrier protein, then the tubes were centrifuged at 1,000 xg for 5 minutes. The pellet was dissolved in 100 [A 1 m NaOHand reprecipitated by adding the 1 ml 10%TCA. The pellet was washed three times in this manner and finally filtered on glass filter paper. Radioactivity on filters was determined by liquid scintillation counting.
Chemicals
Radioactive compounds were obtained from New England Nuclear (Boston, MA, U.S.A.). PDBu, cytochalasin D, phosphatidylinositol and histone III-S were obtained from Sigma Chem. Co. (St. Louis, MO, U.S.A.). RPMI1640 medium was obtained from Nissui Seiyaku (Tokyo, Japan). Sera were obtained from Flow Laboratories (North Ryde, N.S.W., Australia). H7 was obtained from Seikagaku Kogyo Co., Ltd. (Tokyo, Japan). DEAE-Sephacel was obtained from Pharmacia (Uppsala, Sweden). Tautomycin and quinomycin were purified respectively, from the broth filtrate and the mycelium extract of unidentified actinomycetes.
Results

Induction of Bleb Formation by Tautomycin
An active tumor promotor, PDBu,induced many blebs on the surface of K562 humanchronic 
K562 cells (105 cells/ml)
were cultured with tautomycin 1 (H), 0.3 (A) and 0.1 (à") jug/ml or without the antibiotic (O). Viable cells were counted by dye-exclusion test using trypan blue.
myeloid leukemia cells. Bleb formation was also induced by cytochalasin D, a potent inhibitor of polymerization of actin filaments8>9). Tautomycin induced a similar morphological change (Fig. 1) . It was transient and blebs on the cell surface disappeared on further exposure to the antibiotic. Time required to induce bleb formation depended on the concentration of tautomycin. 30 /Jg/ml tautomycin induced it within 10 minutes whereas 1 jug/mi required 2 hours. At 0.3 jug/ml, it was only observed after 20 hour-exposure, concentra-935 tions less than 0.3^g/ml have no inducing activity (Fig. 2) . PDBualso induced bleb formation within 10 minutes but it was maintained for more than 2 hours. Cytochalasin D (1^g/ml) also induced bleb formation within 10 minutes and, like tautomycin, these blebs disappeared within 60 minutes (Fig. 1 ). Fig. 3 shows growth inhibitory effect of tautomycin on K562 cells. The MIC was 0.3 /^g/rnl and lower than this concentration it did not affect the growth, this correlated with the bleb forming activity.
Effect on NBTReducing Activity of Mature Granulocytes and on the Differentiation of HL60 HumanPromyelocytic Leukemia Cells HL60 can be induced to differentiate into mature granulocytes by various agents and tumor promoters induce the activity to reduce NBTin these differentiated cells10-n). In the experiment shown in Table 1, HL60 cells were differentiated by incubating with quinomycin for 3 days. Resultant cells exhibited granulocyte-like phenotypes and 50% of them reduced NBTin response to PDBu. In contrast, tautomycin up to 100 //g/ml and cytochalasin D had only negligible effect. Tumorpromoters induce differentiation of HL60cells to mature macrophages and the differentiated cells spread and adhere to the bottom of plastic dishes5»12>13). Table 2 shows the number of spreading cells after a 24 hour-incubation. 25.8 % of cells cultured with PDBu spread on the bottom whereas no cells exhibited a morphological change in response to tautomycin and cytochalasin D. Both agents inhibited PDBu-induced spread of HL60 cells.
Effect of Binding of [3H]PDBu to K562 Cells
Aboveresults suggest that tautomycin has a different biological activity on intact cells from PDBu. This was further demonstrated by the effect on the binding of PDButo the surface receptor of K562. K562 cells were incubated in the presence of 10 ng/ml PDBuand the antibiotic and specific binding of [3H]PDBu determined. 10^g/ml tautomycin, although inducing bleb formation within 10 minutes, did not cause a significant inhibition (Table 3 ), suggesting that tautomycin binds to the cells at a distinct site from PDBu.
Effect on PKC A kinetic study of bleb formation (Fig. 1) and the results of Tables 1 and 2 suggest the similarity of tautomycin and cytochalasin D. Thus, a direct effect of these agents on PKCextracted from K562 
Discussion
In this paper, we have shown the induction of morphological change by tautomycin, similar to that induced by tumor promoters of the phorbol ester-type. Our foregoing studies suggested two possible mechanism for bleb formation, activation of PKCand inhibition of polymerization of actin filaments3). Kinetic studies indicated that tautomycin was similar to cytochalasin D. In addition neither tautomycin nor cytochalasin D induced NBTreducing activity of mature granulocytes and differentiation of HL60 cells. However, tautomycin but not cytochalasin D directly activated PKC extracted from K562 cells. Because tautomycin did not inhibit binding of [3H]PDBu, the mechanism of activation of PKCby tautomycin must be different from that by phorbol esters. Since PKCused in this study was only partially purified, interaction with other unknownsubstances which affected the PKCactivity, cannot be excluded.
The result that tautomycin activated PKCin a cell-free system but did not induce NBTreducing activity and differentiation of HL60cells, suggest that a quantitative activation of PKCalone is not sufficient to explain the multifunctional biological activities of phorbol esters. Qualitative modulation, for example, of phosphorylation of specific substrates by phorbol ester-activated PKCor a PKCindependent pathway may exist. In this respect, translocation of PKCby phorbol esters6»15) is noteworthy. Tautomycin could be a useful tool to distinguish dependency on phorbol esters of the biological reactions involving the function of PKC. 
